Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loading dose schedules of oral vitamin D3 (30,000 IU) in vitamin D deficient adults
2018-000508-40Phase 3Completed
- Sponsor
- Pharma Patent
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cholecalciferol in Vitamin D deficiency (VDD) (2 arms), sponsored by Pharma Patent. Primary endpoint: Primary efficacy endpoint. Started Apr 2018; status: completed.
02
Drugs
cholecalciferol
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2018-000508-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000508-40.